Key EventShareholders approved FY2025-26 financial statements and declared final dividend
ImpactThe company finalized FY2025-26 results and governance appointments, signaling operational closure and continuity in leadership.Sign up to read impact
Key EventAcutaas Chemicals inaugurates new pilot plant for high-potency API development
ImpactThe new pilot plant strengthens the company's R&D capabilities for high-potency pharmaceutical intermediates, potentially expanding its product pipeline and market opportunities.Sign up to read impact
Key EventAcutaas Chemicals reported FY25-26 results with 33% revenue growth, 107% EBITDA growth, and proposed βΉ2.50/share dividend.
ImpactAcutaas Chemicals is transitioning from a pharma intermediates-focused firm to a diversified specialty chemicals leader with strong growth in high-value segments, robust financials, and sustainability credentials, supported by strategic global expansion.Sign up to read impact